SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939798-19-000017
Filing Date
2019-04-05
Accepted
2019-04-05 16:34:24
Documents
2
Period of Report
2019-04-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 GTBP 8-K FILING OF CERTIFICATE OF DESIGNATION gtbpeightkfivethree.htm 8-K 12602
2 CERTIFICATE OF DESIGNATION exhibitthreeone.htm EX-3.1 34670
  Complete submission text file 0000939798-19-000017.txt   48750
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 19735539
SIC: 2834 Pharmaceutical Preparations